Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?

<p>Abstract</p> <p>Background</p> <p>There has been substantial increase in use of androgen deprivation therapy as adjuvant management of prostate cancer. However, this leads to a range of musculoskeletal toxicities including reduced bone mass and increased skeletal fra...

Full description

Bibliographic Details
Main Authors: Newton Robert U, Taaffe Dennis R, Spry Nigel, Cormie Prue, Chambers Suzanne K, Gardiner Robert A, Shum David HK, Joseph David, Galvão Daniel A
Format: Article
Language:English
Published: BMC 2012-09-01
Series:BMC Cancer
Subjects:
Online Access:http://www.biomedcentral.com/1471-2407/12/432